Neurogenetics : scientific and clinical advances /: scientific and clinical advances. (2006)
- Record Type:
- Book
- Title:
- Neurogenetics : scientific and clinical advances /: scientific and clinical advances. (2006)
- Main Title:
- Neurogenetics : scientific and clinical advances
- Further Information:
- Note: Edited by David R. Lynch ; associate editor Jennifer M. Farmer.
- Other Names:
- Lynch, David R (David Robinson)
- Contents:
- Front cover; Foreword; Preface; Contents; Contributors; 1 Neurogenetics in the Clinic; FACTORS SUGGESTING A NEUROGENETIC DISORDER; NEUROGENETIC DISEASES ''HIDING'' IN NONSPECIFIC CATEGORIES; IMPORTANCE OF FAMILY HISTORY; ASSESSMENT OF SPORADIC CASES; GENETIC COUNSELING; GENETIC TESTING; NEUROGENETICS INFORMATION RESOURCES; AN INTEGRATED CLINICAL NEUROGENETICS STRATEGY; REFERENCES; 2 Genetic Testing for Neurological Disorders; INTRODUCTION; PRINCIPLES OF GENETIC INHERITANCE; Reduced Penetrance, Variable Expressivity, Manifesting Carriers; Splitting. GENOTYPE CHANGES AND THEIR SIGNIFICANCE IN PHENOTYPIC APPEARANCEGENE MUTATIONS AND ASSAYS TO DETECT THEM; CLINICAL USE OF GENE TESTS; Diagnostic Genetic Testing; Predictive Testing; Prenatal and Preimplantation Testing; Carrier Testing; RESOURCES FOR THE CLINICIAN; REFERENCES; 3 Genetic Counseling; INTRODUCTION; ARE GENETIC DISORDERS UNIQUE?; WHO ARE GENETIC COUNSELORS?; THE PROCESS OF GENETIC COUNSELING; GENETIC FAMILY HISTORY-THE PEDIGREE; PEDIGREE ANALYSIS AND RISK PERCEPTION; SUMMARY; REFERENCES; 4 Gene Therapy for Inherited Diseases of the Central Nervous System; INTRODUCTION. GENERAL PROPERTIES OF CNS GENE THERAPYCANDIDATE DISEASES FOR GENE THERAPY IN THE CNS; Autosomal Recessive Mutations of Cytoplasmic or Nuclear Proteins; Dominant Negative Mutations; Autosomal Recessive Mutations Causing Accumulation of Diffusible Toxins; Lysosomal Storage Disease; Disease Severity, Diagnosis, and Age of Treatment Initiation; ANIMALFront cover; Foreword; Preface; Contents; Contributors; 1 Neurogenetics in the Clinic; FACTORS SUGGESTING A NEUROGENETIC DISORDER; NEUROGENETIC DISEASES ''HIDING'' IN NONSPECIFIC CATEGORIES; IMPORTANCE OF FAMILY HISTORY; ASSESSMENT OF SPORADIC CASES; GENETIC COUNSELING; GENETIC TESTING; NEUROGENETICS INFORMATION RESOURCES; AN INTEGRATED CLINICAL NEUROGENETICS STRATEGY; REFERENCES; 2 Genetic Testing for Neurological Disorders; INTRODUCTION; PRINCIPLES OF GENETIC INHERITANCE; Reduced Penetrance, Variable Expressivity, Manifesting Carriers; Splitting. GENOTYPE CHANGES AND THEIR SIGNIFICANCE IN PHENOTYPIC APPEARANCEGENE MUTATIONS AND ASSAYS TO DETECT THEM; CLINICAL USE OF GENE TESTS; Diagnostic Genetic Testing; Predictive Testing; Prenatal and Preimplantation Testing; Carrier Testing; RESOURCES FOR THE CLINICIAN; REFERENCES; 3 Genetic Counseling; INTRODUCTION; ARE GENETIC DISORDERS UNIQUE?; WHO ARE GENETIC COUNSELORS?; THE PROCESS OF GENETIC COUNSELING; GENETIC FAMILY HISTORY-THE PEDIGREE; PEDIGREE ANALYSIS AND RISK PERCEPTION; SUMMARY; REFERENCES; 4 Gene Therapy for Inherited Diseases of the Central Nervous System; INTRODUCTION. GENERAL PROPERTIES OF CNS GENE THERAPYCANDIDATE DISEASES FOR GENE THERAPY IN THE CNS; Autosomal Recessive Mutations of Cytoplasmic or Nuclear Proteins; Dominant Negative Mutations; Autosomal Recessive Mutations Causing Accumulation of Diffusible Toxins; Lysosomal Storage Disease; Disease Severity, Diagnosis, and Age of Treatment Initiation; ANIMAL MODELS OF GENETIC CNS DISORDERS; LYSOSOMAL STORAGE DISEASE: ANIMAL MODELS AS A PARADIGM FOR CNS GENE THERAPY; GENE DELIVERY VEHICLES; Liposomal Delivery Systems; Viral Delivery Systems; Ex Vivo Methods in Gene Therapy; SUMMARY; ACKNOWLEDGMENTS. TESTING A BLOOD SAMPLE FROM SOMEONE WHO HAS JUST COMMITTED SUICIDETESTING A PREGNANCY; GIVING INFORMED CONSENT FOR INDIVIDUALS WITH COGNITIVE/PSYCHIATRIC IMPAIRMENT; INSURANCE ISSUES; ANONYMOUS TESTING; LEGAL CASES; RESOURCES; SUMMARY; RECOMMENDED READING; REFERENCES; 6 Autosomal Dominant Charcot-Marie-Tooth Disease and Related Disorders; SCOPE OF THIS CHAPTER; CMT: BACKGROUND AND GENERAL CLINICAL FEATURES; ELECTROPHYSIOLOGICAL CLASSIFICATION OF CMT; MAJOR FORMS OF DEMYELINATING CMT1 Genetics of CMT1; CMT1: Etiology and Pathogenesis; CMT1A: The Peripheral Myelin Protein-22 Gene. … (more)
- Publisher Details:
- New York : Taylor & Francis
- Publication Date:
- 2006
- Extent:
- 1 online resource (xxi, 755 pages), illustrations
- Subjects:
- 616.8/0442
Nervous system -- Diseases -- Genetic aspects
Neurogenetics
Nervous System Diseases -- genetics
Genetics, Medical
Nervous system diseases -- Genetics
HEALTH & FITNESS -- Diseases -- Nervous System (incl. Brain)
MEDICAL -- Neurology
Nervous system -- Diseases -- Genetic aspects
Neurogenetics
Online resources - Languages:
- English
- ISBNs:
- 0849358361
9780849358364
9780824729424
0824729420 - Related ISBNs:
- 0824729420
- Notes:
- Note: Includes bibliographical references and index.
Note: Print version record. - Access Rights:
- Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
- Access Usage:
- Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD.DS.155642
- Ingest File:
- 01_117.xml